Courtemanche Craig F. Jr. 4

4 · PROCORE TECHNOLOGIES, INC. · Filed Mar 12, 2026

AI-generated summary of this filing

Updated Mar 13, 2026

Procore (PCOR) Chairman Craig Courtemanche Exercises Options, Sells 56,121 Shares

What Happened

Craig F. Courtemanche, Jr., Chairman of the Board at Procore Technologies (PCOR), exercised 56,121 option shares on March 10, 2026 at an exercise price of $2.42 per share (cost $135,813) and sold the same 56,121 shares in open-market transactions that day for aggregate proceeds of approximately $3.21 million.
The sales were executed in three reported blocks (34,969; 19,859; 1,293 shares) at weighted-average prices reported and listed individually ($56.99, $57.58, $58.41). The exercise and immediate sale is effectively a cashless exercise (options converted to shares and then sold).

Key Details

Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (no late filing indicated in this report).
Exercise (code M): 56,121 shares @ $2.42 (acquired) — total exercise cost $135,813.
Sales (code S): 34,969 @ $56.99; 19,859 @ $57.58; 1,293 @ $58.41 — total proceeds ≈ $3,211,888.
Footnotes: Sales were made pursuant to a 10b5-1 trading plan dated Dec 9, 2025 (F1). Two sale blocks report weighted-average prices with ranges $56.36–$57.35 and $57.36–$58.03 (F2, F3); the filer can provide breakdowns on request. Some holdings are held in family/irrevocable trusts (F4–F6). Vesting schedule for the option award is described in F7.
Shares owned after the transaction are not specified in the provided excerpt of the filing.

Context

This is a routine insider exercise-and-sell: options were exercised at a low strike and the resulting shares were sold the same day under a pre-established 10b5-1 plan. Such transactions often reflect cashing out option gains or covering exercise/tax obligations rather than a directional statement about company prospects.

Form 4

Period: 2026-03-10

DirectorOther

Transactions

Exercise/Conversion
Common Stock
2026-03-10$2.42/sh+56,121$135,813→ 983,701 total
Sale
Common Stock
[F1][F2]
2026-03-10$56.99/sh−34,969$1,992,883→ 948,732 total
Sale
Common Stock
[F1][F3]
2026-03-10$57.58/sh−19,859$1,143,481→ 928,873 total
Sale
Common Stock
[F1]
2026-03-10$58.41/sh−1,293$75,524→ 927,580 total
Exercise/Conversion
Stock Option (Right to Buy)
[F7]
2026-03-10$2.42/sh−56,121$135,813→ 392,854 total
Exercise: $2.42Exp: 2026-11-10→ Common Stock (56,121 underlying)

Holdings

Footnotes (7)

[F1]These shares sold pursuant to a 10b5-1 plan dated December 9, 2025.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $56.36 to $57.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $57.36 to $58.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]These shares are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012.
[F5]These shares are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021.
[F6]These shares are held by The Courtemanche 2016 Irrevocable Trust.
[F7]The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date.

Signature

/s/ Benjamin C. Singer, Attorney-in-Fact|2026-03-12

1 file